ENZYME MUTANT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120100530A1
SERIAL NO

13147171

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to constructs comprising a nucleic acid binding protein and a surface. At least one native accessible cysteine residue is removed from the binding protein. The binding protein is attached to the surface via one or more accessible cysteine residues. The removal of other accessible cysteine residues from the protein allows control attachment to the surface. The constructs can be used to generate transmembrane pores having a nucleic acid binding protein attached thereto. Such pores are particularly useful for sequencing nucleic acids. The enzyme handles the nucleic acid in such a way that the pore can detect each of its component nucleotides by stochastic sensing.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
Oxford Nanopore Technologies Ltd.KIDLINGTON, GB11

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jayasinghe, Lakmal Oxford, GB 14 60
Knaggs, Michael Oxford, GB 11 64
Mckeown, Brian Oxon, GB 11 44
Milton, John Oxford, GB 38 787
Moysey, Ruth Oxford, GB 9 15
White, James Oxford, GB 81 605

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Oxford Nanopore Technologies Ltd. (1)
* 2011/0229,877 ENZYME-PORE CONSTRUCTS 6 2009
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
9732381 Method for sequencing a heteropolymeric target nucleic acid sequence 0 2010
 
Oxford Nanopore Technologies Ltd. (1)
9551023 Sample preparation method 0 2013
 
OXFORD UNIVERSITY INNOVATION LIMITED (1)
9562887 Methods of enhancing translocation of charged analytes through transmembrane protein pores 0 2014
* Cited By Examiner